The Global Market for EPA/DHA Omega-3 Products

Keywords : Pharmaceutical, clinical nutrition, Clinical Nutritional Product, pharmaceutical sale

Packaged Facts projects the market value of EPA/ DHA omega-3 packaged products to reach $34.7 billion in 2016, representing a compound annual growth rate (CAGR) of 6.4% over 2011. Expanding public awareness of EPA/DHA omega-3 health benefit through positive media coverage of scientific research findings, as well as developments in regulatory markets, will contribute significantly to continued growth in the global market for EPA/DHA omega-3 produc...

More »

Packaged Facts projects the market value of EPA/ DHA omega-3 packaged products to reach $34.7 billion in 2016, representing a compound annual growth rate (CAGR) of 6.4% over 2011. Expanding public awareness of EPA/DHA omega-3 health benefit through positive media coverage of scientific research findings, as well as developments in regulatory markets, will contribute significantly to continued growth in the global market for EPA/DHA omega-3 products. Other factors that will continue to create a positive growth environment for EPA/DHA omega-3 products include:

• Consumer interest in functional food and fortified product line expansions;


• Increasing demand for fortified infant formula due to population growth and rising middle class in emerging economies;


• Continued popularity of EPA/DHA omega-3 nutritional supplement products, including krill oil and vegetarian algae-based supplements;


• Introduction of pharmaceutical-grade products into South America and approval of generic forms in existing markets;


• Expanding clinical nutrition market opportunities for disease- and disorder-specific formula applications, created through additional R & D and aggressive marketing by ingredient suppliers; and


• Premiumization of pet foods due to humanization of companion animals.

This report, based on research commissioned by the Global Organization for EPA and DHA Omega-3 (GOED) and featured at the GOED Exchange 2012 conference in Boston in June 2012, focuses on the market for EPA / DHA omega-3 packaged products by category and global region. The products included in this study are those fortified with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). Excluded from scope of this study are non-fortified fish/ fish products as well as products that only contain alpha linoleic acid (ALA) omega-3.



The geographic scope of this report is global, broken out into four regions: North America (United States and Canada); Europe (Scandinavia, Western Europe, Eastern Europe and Russia); Asia Pacific (China, Japan, South and Southeast Asia, Australia, New Zealand and Oceania); and Rest of World (Latin America, Middle East and Africa). Six categories of packaged consumer products are covered by this report: infant formula; fortified foods and beverages; nutritional supplements; pharmaceuticals; clinical nutrition (enteral and parenteral) products; and pet food, treats and supplements.



The base year for market sizing is 2011, with projections for 2016. All market size figures and projections are calculated in U.S. dollars.

Global Pharmaceutical Industry

Chapter 1: Executive Summary

Scope of Report

Report Methodology

Market Size and Composition

Market Composition by Geographic Region

Table 1-1: EPA/DHA Omega-3 Products: Global Market Size and Share by Region, 2011

Figure 1-1: EPA/DHA Omega-3 Products: Global Market Share by Region, 2011

Market Composition by Product Category

Table 1-2: EPA/DHA Omega-3 Products: Global Market Size and Share by Category, 2011

Figure 1-2: EPA/DHA Omega-3 Products: Global Market Share by Category, 2011

Factors to Market Growth

Projected Market Growth

Table 1-3: Global Market for EPA/DHA Omega-3 Products,2011 vs. 2016

Projected Growth by Geographic Region

Table 1-4: EPA/DHA Omega-3 Products: Projected Global Market Size and Share by Region, 2016

Figure 1-3: EPA/DHA Omega-3 Products: Projected Global Market Share by Region, 2016

Projected Growth by Product Category

Table 1-5: EPA/DHA Omega-3 Products: Global Market Size and Share by Category, 2016

Figure 1-4: EPA/DHA Omega-3 Products: Global Market Share by Category, 2016

Chapter 2: Market Review

Global Market Size and Composition

Table 2-1: EPA/DHA Omega-3 Products: Global Market Size and Share by Region, 2011

Figure 2-1: Share of EPA/DHA Omega-3 Products by Global Region, 2011

Market Composition by Product Category

Table 2-2: EPA/DHA Omega-3 Products: Global Market Size and Share by Category, 2011

Figure 2-2: Share of EPA/DHA Omega-3 Product Sales by Global Region, 2011

Category Focus: Infant Formula

Category Value by Region

Table 2-3: DHA/ARA-Fortified Infant Formulas: Global Market Size and Share by Region, 2011

Figure 2-3: Share of DHA/ARA-Fortified Infant Formula Sales by Global Region, 2011

U.S. Market Trends

Emerging Market Trends

Figure 2-4: Birth Rates by Global Regions, 2010

Figure 2-5: Birth Rates for Selected Countries, 2010-2015

Category Focus: Fortified Foods and Beverages

Category Value by Region

Table 2-4: EPA/DHA-Fortified Foods & Beverages: Global Category Size and Share by Region, 2011

Figure 2-6: Category Share of EPA/DHA-Fortified Food & Beverage Sales by Global Region, 2011

Dairy Products

Beverages and Juices

Baby Food and Pediatric Juices

Breads and Bakery

Processed Meats

Cooking Oils

Figure 2-7: Estimated Average Daily Intakes of EPA/DHA by Country (in mg/day based on 2,000 kCAL diet)

Prepared Products

Other Foods

Category Focus: Nutritional Supplements

Category Value by Global Region

Table 2-5: EPA/DHA Nutritional Supplements: Global Category Size and Share by Region, 2011

Figure 2-8: Category Share of EPA/DHA Omega-3 Nutritional

Supplements by Global Region, 2011

Category and Regional Trends

Category Focus: Pharmaceuticals

Lovaza

Epadel

Category Value by Region

Table 2-6: EPA/DHA Pharmaceuticals: Global Category Size and Share by Region, 2011

Figure 2-9: Share of EPA/DHA Pharmaceutical Sales by Global Region, 2011

Category Perspective

Table 2-7: Omega-3 Fatty Acid Pharmaceutical Products in Development

Source: GOED (Global Organization for EPA and DHA Omega-3)

Table 2-8: Potential Generic Drug Manufacturer Market Entry

Category Focus: Clinical Nutrition

Category Value by Region

Table 2-9: Clinical Nutrition Products with EPA/DHA: Global Category Size and Share by Region, 2011

Figure 2-10: Share of Sales for Clinical Nutrition Products with EPA/DHA by Global Region, 2011

Established and Emerging Markets

Figure 2-11: Population Aged 65 or Older by Country: 2010 vs. 2015

Category Focus: Pet Food, Treats and Supplements

Category Value by Region

Table 2-10: EPA/DHA-Fortified Pet Food, Treats, and Supplements: Global Category Size and Share by Region, 2011

Figure 2-12: Share of Sales for Pet Food, Treats, or Supplements with EPA/DHA by Global Region, 2011

Market Scales Up and Expands Out

Projected Sales and Shares by Geographic Region

Table 2-11: EPA/DHA Omega-3 Products: Projected Global Market Size and Share by Region, 2016

Figure 2-13: EPA/DHA Omega-3 Products: Projected Global Market Share by Region, 2016

Figure 2-14: Projected CAGR for EPA/DHA Omega-3 by Region, 2011-2016

Projected Sales and Shares by Product Category

Figure 2-15: Projected Global Market Shares for EPA/DHA Omega-3 Products by Category, 2016

Table 2-12: Projected Market for DHA/ARA-Fortified Infant Formula: Overall and by Global Region, 2011-2016

Table 2-13: Projected Market for EPA/DHA-Fortified Food & Beverages: Overall and by Global Region, 2011-2016

Table 2-14: Projected Market for EPA/DHA Nutritional Supplements:Overall and by Global Region, 2011-2016

Table 2-15: Projected Market for EPA/DHA Pharmaceuticals:Overall and by Global Region, 2011-2016

Table 2-16: Projected Market Clinical Nutrition Products with EPA/DHA:Overall and by Global Region, 2011-2016

Table 2-17: Projected Market for EPA/DHA-Fortified Pet Food, Treats,and Supplements: Overall and by Global Region, 2011-2016

Summary of Factors to Future Growth

Pharmaceutical in World